Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man.
D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D002752:Chlorthalidone / Q000494:pharmacology*; D003094:Collagen / Q000494:pharmacology; D001728:Dicumarol / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006400:Hematocrit; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D012964:Sodium / Q000494:pharmacology; D014859:Warfarin / Q000097:blood / Q000494:pharmacology
D000925:Anticoagulants; D014859:Warfarin; D000244:Adenosine Diphosphate; D001728:Dicumarol; D000255:Adenosine Triphosphate; D003094:Collagen; D012964:Sodium; D002752:Chlorthalidone; D001241:Aspirin; D004837:Epinephrine